Landos Biopharma Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis (NCT04862741) | Landos Biopharma Inc. | 2021-05-05 |
| Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers (NCT04458805) | Landos Biopharma Inc. | 2020-07-10 |
Track Landos Biopharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.